GHRP-2 (Growth Hormone Releasing Peptide-2), also known as Pralmorelin, is a synthetic hexapeptide and one of the most widely studied growth hormone secretagogues in peptide research. It functions as a ghrelin receptor (GHS-R1a) agonist, stimulating the pituitary gland to release endogenous growth hormone in a pulsatile, physiologically relevant manner.
Unlike GHRH analogues, GHRP-2 acts through a distinct receptor pathway and demonstrates a strong, dose-dependent GH-releasing effect, making it a valuable tool for researchers investigating the somatotropic axis, pituitary responsiveness, and neuroendocrine signalling.
Research has explored GHRP-2 in the context of GH deficiency models, body composition studies, appetite regulation, and anti-inflammatory mechanisms. It has also been investigated alongside GHRH analogues such as CJC-1295, where synergistic GH release has been observed in preclinical settings.
Storage: Store at -20°C. Upon reconstitution, keep refrigerated at 4°C and use within 28 days. Protect from light and moisture.
Molecular Formula
C₄₅H₅₅N₉O₆
Molecular Weight
817.9 g/mol
Purity
>98%
CAS Number
158861-67-7
Form
Lyophilised Powder
Research Applications
Growth hormone secretion studies, Neuroendocrine signalling research, Pituitary function assessment, Body composition and metabolism research, Appetite regulation studies, GH deficiency modelling
For research purposes only. Not for human use.
Reviews
There are no reviews yet.